Argen X SE ADR

ARGXNASDAQ · USD
960.04USD0.00 (-2.17%)
529

Argen X SE ADR (ARGX) Expected Move

ARGX expected move through Nov 20, 2026 is 4.1%, with 4 days to expiration. The implied range is $920.69 to $999.39, based on the previous trading day's options prices.

Read more

Tracking the ARGX expected move helps you see how far Argen X SE ADR's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Argen X SE ADR's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the ARGX expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For ARGX, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The ARGX expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Argen X SE ADR is unlikely to go.

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the ARGX expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Argen X SE ADR expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about ARGX.

ARGX Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Nov 20, 20264$39.354.1%$999.39$920.69
Dec 18, 202632$97.1510.1%$1,057.19$862.89
Jan 15, 202760$131.2813.7%$1,091.32$828.77
Feb 19, 202795$158.1516.5%$1,118.19$801.89

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →